Linked Life Data

15081648

Source:http://linkedlifedata.com/resource/pubmed/id/15081648

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9416
pubmed:dateCreated
2004-4-14
pubmed:abstractText
Restrictive valvular heart disease has been reported in patients with Parkinson's disease treated with pergolide. However, few data are available on frequency, severity, dose dependency, and reversibility of pergolide-induced disease, nor on the pulmonary pressures of these patients. We aimed to clarify these characteristics in a large group of patients.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1474-547X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
363
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1179-83
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.
pubmed:affiliation
Department of Cardiology, AZ VUB, Brussels, Belgium. guy.vancamp@az.vub.ac.be
pubmed:publicationType
Journal Article